Abstract: This article investigates the adaptive resource allocation scheme for digital twin (DT) synchronization optimization over dynamic wireless networks. In our considered model, a base station ...

Relaxed Exploration Constrained Reinforcement Learning. Shahaf S. Shperberg, Bo Liu, and Peter Stone. @InProceedings{shahaf_shperberg_AAMAS_2024, author = {Shahaf S. Shperberg and Bo Liu and Peter ...

Charles River Laboratories International, Inc. CRL reported third-quarter 2025 adjusted earnings per share (EPS) of $2.43, down 6.2% year over year. However, the figure surpassed the Zacks Consensus ...

Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

The FDA's complete response letter for Dasynoc was due to manufacturing issues, delaying its approval for CML and ALL treatment. Dasynoc, a bioequivalent formulation of dasatinib, offers a 30% lower ...

The establishment of a new regulatory body to oversee churches and faith institutions has reignited a national debate about the state’s role in religion, with critics warning that the initiative could ...

Replimune Group, Inc. received a surprising FDA Complete Response Letter for RP1, citing inadequate trial design and concerns over data interpretation. RP1's delayed approval and the need for a new ...

The FDA issued a second CRL for rivoceranib and camrelizumab, with undisclosed reasons for non-approval. The combination therapy showed improved overall survival and progression-free survival compared ...